NCT05675436: Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Sickle Cell Anemia, Sickle Cell Thalassemia, Sickle Cell Pain, Hbss, Hbsc, Sickle Beta Thalassemia, Sickle Beta Zero Thalassemia, Sickle Cell Syndrome Variant